ClearPoint Neuro, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value
ClearPoint Neuro, Inc. (CLPT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value of $7.05 per share for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-26.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue · last filed 2025-02-26
- ClearPoint Neuro, Inc. share-based compensation arrangement by share-based payment award, options, nonvested options forfeited, weighted average grant date fair value for fiscal 2024 was $7.05.
- ClearPoint Neuro, Inc. share-based compensation arrangement by share-based payment award, options, nonvested options forfeited, weighted average grant date fair value for fiscal 2022 was $10.33, a 76.58% increase from fiscal 2021.
- ClearPoint Neuro, Inc. share-based compensation arrangement by share-based payment award, options, nonvested options forfeited, weighted average grant date fair value for fiscal 2021 was $5.85, a 82.38% decline from fiscal 2020.
- ClearPoint Neuro, Inc. share-based compensation arrangement by share-based payment award, options, nonvested options forfeited, weighted average grant date fair value for fiscal 2020 was $33.20, a 22.18% decline from fiscal 2019.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value 12 month as first filed |
|---|---|---|
| 2024-12-31 | $7.05 10-K · filed 2025-02-26 | |
| 2022-12-31 | $10.33 10-K · filed 2023-03-01 | |
| 2021-12-31 | $5.85 10-K · filed 2022-03-09 | |
| 2020-12-31 | $33.20 10-K · filed 2021-03-22 | |
| 2019-12-31 | $42.66 10-K · filed 2021-03-22 | |
| 2018-12-31 | $25.22 10-K · filed 2020-03-27 | |
| 2017-12-31 | $16.50 10-K · filed 2019-04-01 | |
| 2016-12-31 | $28.66 10-K · filed 2018-03-21 | |
| 2015-12-31 | $23.76 10-K · filed 2017-03-09 | $0.59 10-K · filed 2016-03-25 |
| 2014-12-31 | $0.76 10-K · filed 2016-03-25 | $0.58 10-K · filed 2015-03-17 |
| 2013-12-31 | $0.76 10-K · filed 2015-03-17 | |
| 2012-12-31 | $0.85 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |